Cargando…
UK BRCA mutation testing in patients with ovarian cancer
Despite the increasing clinical importance of germline BRCA mutation status in managing women with ovarian cancer, few patients are currently being tested. The traditional means of selecting patients for BRCA mutation testing using restrictive criteria will miss many women with a mutation. To expand...
Autor principal: | George, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816269/ https://www.ncbi.nlm.nih.gov/pubmed/26669451 http://dx.doi.org/10.1038/bjc.2015.396 |
Ejemplares similares
-
Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007) -
BRCA mutated pancreatic cancer: A change is coming
por: Rosen, Michael N, et al.
Publicado: (2021) -
BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
por: Maccaroni, Elena, et al.
Publicado: (2021) -
It is not all about BRCA: Cullin-Ring ubiquitin Ligases in ovarian cancer
por: Carlucci, A, et al.
Publicado: (2015) -
A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer
por: Eccleston, Anthony, et al.
Publicado: (2017)